MEMBER EXCLUSIVE:
Hosted by Alan Booth, managing editor of Regulatory Rapporteur, this episode of RegRapPod is an extended conversation with authors Priti Shah and Anna Litsiou following on from their article in the April issue [Vol. 20 #4]. Priti and Anna share insights around the regulatory process of AstraZeneca’s COVID-19 vaccine − Vaxzevria.
NOTE TO LISTENERS:
If you have already listened to our launch programme, you will have heard the first question’s discussion already. Therefore, to skip ahead, you can fast forward through the first section of the show and go straight to the rest of the interview by clicking below:
SHOW NOTES:
This podcast was presented by Alan Booth and produced by Daisy Edwards at TOPRA in London.
If you would like to advertise on the RegRapPod, please contact Erik Smit at Erik@topra.org
For any other queries, please contact Daisy at daisy@topra.org,
or write to the Editor at publications@topra.org
No comments yet